Biohaven (BHVN) Minority Interest (2021)
Biohaven (BHVN) posted Minority Interest of $60.0 million for Q4 2021.
Powered by 
Analysis
Biohaven (BHVN) Minority Interest (2021) Analysis & Trends
Biohaven has reported Minority Interest for 1 years, with the latest figure at $60.0 million in Q4 2021.
- Quarterly Minority Interest changed N/A year-over-year to $60.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $60.0 million (changed N/A YoY) and the FY2021 annual result came in at $60.0 million, changed N/A from the prior year.
- Minority Interest held at $60.0 million in Q4 2021 per BHVN's latest filing.
- Over five years, Minority Interest peaked at $60.0 million in Q4 2021 and troughed at $60.0 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Biohaven | 2.37 Bn | 2.10 Bn | - |